Total Payments
$49,113
2024 Payments
$1,318
Companies
35
Transactions
190
Medicare Patients
728
Medicare Billing
$70,575
Payment Breakdown by Category
Other$31,985 (65.1%)
Travel$5,839 (11.9%)
Food & Beverage$5,648 (11.5%)
Research$5,641 (11.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31,985 | 9 | 65.1% |
| Travel and Lodging | $5,839 | 15 | 11.9% |
| Food and Beverage | $5,648 | 149 | 11.5% |
| Unspecified | $5,641 | 17 | 11.5% |
Payments by Type
General
$43,472
173 transactions
Research
$5,641
17 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $23,816 | 41 | $0 (2019) |
| Medtronic USA, Inc. | $14,548 | 23 | $0 (2020) |
| Medtronic, Inc. | $5,777 | 13 | $0 (2024) |
| Genentech, Inc. | $771.25 | 3 | $0 (2020) |
| NeuraSignal Inc. | $700.00 | 1 | $0 (2024) |
| Viz.ai, Inc. | $619.32 | 8 | $0 (2022) |
| Biogen, Inc. | $560.04 | 10 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $212.92 | 9 | $0 (2022) |
| Allergan Inc. | $202.74 | 12 | $0 (2018) |
| Neural Analytics, Inc. | $189.18 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,318 | 7 | NeuraSignal Inc. ($700.00) |
| 2023 | $369.22 | 2 | Medtronic, Inc. ($350.00) |
| 2022 | $3,465 | 15 | Medtronic, Inc. ($3,087) |
| 2021 | $2,559 | 10 | Medtronic, Inc. ($1,956) |
| 2020 | $3,717 | 6 | Medtronic USA, Inc. ($2,975) |
| 2019 | $12,663 | 30 | Medtronic Vascular, Inc. ($8,411) |
| 2018 | $10,535 | 44 | Medtronic USA, Inc. ($7,344) |
| 2017 | $14,487 | 76 | Medtronic Vascular, Inc. ($13,225) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Neuromodulation | ||||||
| 09/25/2024 | NeuraSignal Inc. | — | Travel and Lodging | Cash or cash equivalent | $700.00 | General |
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.54 | General |
| Category: Rare Disease | ||||||
| 08/13/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/29/2024 | Medtronic, Inc. | REVEAL LINQ (Device) | — | Cash or cash equivalent | $350.00 | Research |
| Study: DiVERT Stroke • Category: Cardiac Diagnostics and Monitoring | ||||||
| 02/08/2024 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 02/06/2024 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $74.17 | General |
| Category: Metabolism & Primary Care | ||||||
| 08/17/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/26/2023 | Medtronic, Inc. | REVEAL LINQ (Device) | — | Cash or cash equivalent | $350.00 | Research |
| Study: DiVERT Stroke • Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/01/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: PRIMARY CARE | ||||||
| 08/30/2022 | Medtronic, Inc. | REVEAL LINQ (Device) | — | Cash or cash equivalent | $350.00 | Research |
| Study: DiVERT Stroke • Category: Cardiac Diagnostics and Monitoring | ||||||
| 08/30/2022 | Medtronic, Inc. | REVEAL LINQ (Device) | — | Cash or cash equivalent | $350.00 | Research |
| Study: DiVERT Stroke • Category: Cardiac Diagnostics and Monitoring | ||||||
| 08/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/18/2022 | Medtronic, Inc. | REVEAL LINQ (Device) | — | Cash or cash equivalent | $1,400.00 | Research |
| Study: DiVERT Stroke • Category: Cardiac Diagnostics and Monitoring | ||||||
| 07/05/2022 | Medtronic, Inc. | REVEAL LINQ (Device) | — | Cash or cash equivalent | $437.50 | Research |
| Study: DiVERT Stroke • Category: Cardiac Diagnostics and Monitoring | ||||||
| 06/30/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/18/2022 | Viz.ai, Inc. | Viz.AI LVO (Device) | Food and Beverage | Cash or cash equivalent | $18.44 | General |
| Category: Care Coordination | ||||||
| 05/17/2022 | Viz.ai, Inc. | Viz.AI LVO (Device) | Food and Beverage | Cash or cash equivalent | $46.20 | General |
| Category: Care Coordination | ||||||
| 05/17/2022 | Viz.ai, Inc. | Viz.AI LVO (Device) | Food and Beverage | Cash or cash equivalent | $36.72 | General |
| Category: Care Coordination | ||||||
| 05/12/2022 | Medtronic, Inc. | REVEAL LINQ (Device) | — | Cash or cash equivalent | $525.00 | Research |
| Study: DiVERT Stroke • Category: Cardiac Diagnostics and Monitoring | ||||||
| 02/12/2022 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 02/10/2022 | Viz.ai, Inc. | Viz.AI LVO (Device) | Food and Beverage | Cash or cash equivalent | $59.96 | General |
| Category: Care Coordination | ||||||
| 02/01/2022 | Viz.ai, Inc. | Viz.AI LVO (Device) | Food and Beverage | Cash or cash equivalent | $24.78 | General |
| Category: Care Coordination | ||||||
| 01/31/2022 | Viz.ai, Inc. | Viz.AI LVO (Device) | Food and Beverage | Cash or cash equivalent | $112.54 | General |
| Category: Care Coordination | ||||||
| 11/18/2021 | Viz.ai, Inc. | Viz.AI LVO (Device) | Food and Beverage | Cash or cash equivalent | $266.34 | General |
| Category: Care Coordination | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| DiVERT Stroke | Medtronic, Inc. | $5,163 | 9 |
| Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction | Biogen, Inc. | $478.90 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 190 | 217 | $50,900 | $17,393 |
| 2022 | 6 | 317 | 395 | $79,438 | $29,675 |
| 2021 | 6 | 131 | 161 | $24,597 | $11,097 |
| 2020 | 4 | 90 | 111 | $40,113 | $12,410 |
Total Patients
728
Total Services
884
Medicare Billing
$70,575
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 85 | $22,265 | $7,107 | 31.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $11,470 | $4,522 | 39.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 33 | $4,686 | $1,916 | 40.9% |
| G0508 | Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth | Office | 2023 | 11 | 11 | $5,775 | $1,678 | 29.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 36 | 38 | $5,352 | $1,617 | 30.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 13 | 13 | $1,352 | $553.28 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 68 | 86 | $15,998 | $7,360 | 46.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 75 | 127 | $16,725 | $6,748 | 40.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 55 | 59 | $16,933 | $5,940 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $8,370 | $3,081 | 36.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $6,363 | $2,673 | 42.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 57 | 61 | $11,853 | $2,614 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 17 | $3,196 | $1,259 | 39.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 34 | $6,222 | $3,252 | 52.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 52 | $6,812 | $2,867 | 42.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 40 | $5,440 | $2,790 | 51.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $3,720 | $1,159 | 31.2% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 12 | 12 | $1,248 | $538.80 | 43.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 11 | 11 | $1,155 | $491.04 | 42.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 40 | 40 | $23,520 | $6,716 | 28.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 15 | $6,570 | $2,336 | 35.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 22 | 43 | $6,708 | $2,145 | 32.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 13 | 13 | $3,315 | $1,213 | 36.6% |
About Thomas Devlin, MD PHD
Thomas Devlin, MD PHD is a Neurology healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891723284.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas Devlin, MD PHD has received a total of $49,113 in payments from pharmaceutical and medical device companies, with $1,318 received in 2024. These payments were reported across 190 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($31,985).
As a Medicare-enrolled provider, Devlin has provided services to 728 Medicare beneficiaries, totaling 884 services with total Medicare billing of $70,575. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Chattanooga, TN
- Active Since 06/28/2006
- Last Updated 01/04/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1891723284
Products in Payments
- Solitaire (Device) $10,277
- REVEAL LINQ (Device) $3,763
- Pipeline (Device) $3,314
- Reveal LINQ (Device) $2,079
- LIORESAL (Device) $921.39
- Viz.AI LVO (Device) $619.32
- XARELTO (Drug) $212.92
- Activase (Biological) $182.52
- VNS Therapy (Device) $171.65
- ANDEXXA (Biological) $143.79
- BOTOX NEURO REHAB (Drug) $122.97
- Trevo (Device) $122.25
- CorPath Imaging System (Device) $110.00
- Kcentra (Biological) $98.92
- LINQ II (Device) $89.04
- CHANTIX (Drug) $65.77
- Briviact (Drug) $63.90
- Artis icono floor (Device) $60.00
- NUEDEXTA (Drug) $58.74
- ELIQUIS (Drug) $57.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Chattanooga
David Rankine, Md, MD
Neurology — Payments: $206,453
Neurology $206,453
Tareck Kadrie, Md, MD
Neurology — Payments: $146,246
Neurology $146,246
Dr. Yuchun Han, M.d. & Ph.d, M.D. & PH.D
Neurology — Payments: $54,122
Neurology $54,122
Jake Mckay, Md, MD
Neurology — Payments: $42,646
Neurology $42,646
Chelsea Shugars, Md, MD
Neurology — Payments: $32,447
Neurology $32,447
Sharon Farber, Md, MD
Neurology — Payments: $20,131
Neurology $20,131